Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Publication Day
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Confidential Psychological Support
    • Interim Payments
    • Support Groups
    • Get in touch
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Dr Cumming was the regional transfusion director for Edinburgh and South East Scotland, a professional advocate for plasmapheresis, and was also one of the first three Scottish blood donors to reach 200 donations.

  • Read more about Dr Cumming was the regional transfusion director for Edinburgh and South East Scotland, a professional advocate for plasmapheresis, and was also one of the first three Scottish blood donors to reach 200 donations.

Dr Angela Robinson was an enthusiast for plasmapheresis, and set up a pilot unit in Yorkshire.

  • Read more about Dr Angela Robinson was an enthusiast for plasmapheresis, and set up a pilot unit in Yorkshire.

During this period, government funding was exceptionally constrained, inadequate and difficult to obtain for the redevelopment of BPL and the production of additional plasma for national self-sufficiency.

  • Read more about During this period, government funding was exceptionally constrained, inadequate and difficult to obtain for the redevelopment of BPL and the production of additional plasma for national self-sufficiency.

It was estimated that 74 million international units of Factor 8 could be produced in the UK once the requirements for albumin were met.

  • Read more about It was estimated that 74 million international units of Factor 8 could be produced in the UK once the requirements for albumin were met.

At a meeting of the Blood Products Laboratory, it became clear that PFC's construction would cost more than the sum approved, and that despite a planned 1,500-litre capacity, it would initially only operate at 1,000 litres per week to reduce cost.

  • Read more about At a meeting of the Blood Products Laboratory, it became clear that PFC's construction would cost more than the sum approved, and that despite a planned 1,500-litre capacity, it would initially only operate at 1,000 litres per week to reduce cost.

In Scotland, the national blood service defined self-sufficiency in blood products as the production of enough factor concentrate from a country's own resources to meet clinical need without the need for importation.

  • Read more about In Scotland, the national blood service defined self-sufficiency in blood products as the production of enough factor concentrate from a country's own resources to meet clinical need without the need for importation.

The increasing use of plasmapheresis for collection was pursued as it was a safer base material to manufacture concentrates due to the larger donation that was able to be extracted (the amount of plasma from one donation of whole blood was 40% of that from a donor of plasma by plasmapheresis).

  • Read more about The increasing use of plasmapheresis for collection was pursued as it was a safer base material to manufacture concentrates due to the larger donation that was able to be extracted (the amount of plasma from one donation of whole blood was 40% of that from a donor of plasma by plasmapheresis).

Prescribing choices in England and Wales (being the choices that would be reflected in demand) were being formed when imported commercial Factor 8 filled the gap left by BPL's failure to supply, and this continued into the early 1980's.

  • Read more about Prescribing choices in England and Wales (being the choices that would be reflected in demand) were being formed when imported commercial Factor 8 filled the gap left by BPL's failure to supply, and this continued into the early 1980's.

The quantity of NHS factor concentrate used in Northern Ireland increased dramatically once Northern Irish plasma began being sent to the BPL, as Factor 8 concentrate manufactured at Liberton was sent in return.

  • Read more about The quantity of NHS factor concentrate used in Northern Ireland increased dramatically once Northern Irish plasma began being sent to the BPL, as Factor 8 concentrate manufactured at Liberton was sent in return.

Although Northern Ireland was able to make cryoprecipitate from local blood donors, it was too small to produce factor concentrate itself.

  • Read more about Although Northern Ireland was able to make cryoprecipitate from local blood donors, it was too small to produce factor concentrate itself.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 280
  • Page 281
  • Page 282
  • Page 283
  • Current page 284
  • Page 285
  • Page 286
  • Page 287
  • Page 288
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.